(Q59243317)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10418919%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

The infant rat model adapted to evaluate human sera for protective immunity to group B meningococci (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10418919%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10418919%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

2

H Käyhty

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10418919%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

M Toropainen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10418919%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

L Saarinen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10418919%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

E Rosenqvist

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10418919%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

E A Høiby

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10418919%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

E Wedege

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10418919%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

P H Mäkelä

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10418919%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

language of work or name

English

0 references

publication date

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10418919%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10418919%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10418919%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

20-21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10418919%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

2677-2689

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10418919%20AND%20SRC:MED&resulttype=core&format=json

Meningococcal Disease: Still with Us

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Human immunity to the meningococcus. II. Development of natural immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Effect of group-A meningococcal vaccine in army recruits in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Immunologic response of man to group B meningococcal polysaccharide vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

The relationship between group A and group C meningococcal polysaccharides and serum opsonins in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Killing of Neisseria meningitidis by human neutrophils: implications for normal and complement-deficient individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Comparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Pathogenicity and the microbe in vivo. The 1989 Fred Griffith Review Lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

EXPERIMENTAL MENINGOCOCCAL INFECTION IN MICE

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Neisseria meningitidis infection in mice: influence of iron, variations in virulence among strains, and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

[An animal model for testing the activity of meningococcal polysaccharide vaccine]

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Intranasal infection of infant mice with Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Experimental meningococcal meningitis in the infant rat

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

The class 1 outer membrane protein of Neisseria meningitidis produced in Bacillus subtilis can give rise to protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

The antibody response to a prototype liposome vaccine containing Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Sero- and subtypes of group B meningococci causing invasive infections in Finland in 1976-87

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Opsonophagocytic activity induced by chimeric antibodies of the four human IgG subclasses with or without help from complement

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Restoration of antibody binding to blotted meningococcal outer membrane proteins using various detergents

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Meningococcal serotypes and serogroup B disease in north-west Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

Protection against group B meningococcal disease. I. Comparison of group-specific and type-specific protection in the chick embryo model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900049-3

7 January 2021

10.1016/S0264-410X(99)00049-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10418919%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference